Aviva PLC Catalent, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Catalent, Inc. stock. As of the latest transaction made, Aviva PLC holds 6,894 shares of CTLT stock, worth $437,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,894

Previous 6,906 0.17%

Holding current value

$437,631

Previous $388,000 7.47%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $673 - $731	-12 Reduced 0.17%	6,894 $417,000
Q1 2024 May 14, 2024	SELL	$42.56 - $59.82 $3,702 - $5,204	-87 Reduced 1.24%	6,906 $389,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $11,580 - $13,152	262 Added 3.89%	6,993 $318,000
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $743,625 - $1.22 Million	-16,365 Reduced 70.86%	6,731 $442,000
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $21,522 - $42,120	-520 Reduced 2.2%	23,096 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $6,946 - $10,857	96 Added 0.41%	23,616 $1.71 Million
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $635,688 - $831,424	-7,290 Reduced 23.66%	23,520 $2.52 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $1.91 Million - $2.52 Million	-20,232 Reduced 39.64%	30,810 $3.42 Million
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $162,376 - $188,857	1,358 Added 2.73%	51,042 $6.54 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $304,475 - $397,014	-2,789 Reduced 5.32%	49,684 $6.61 Million
Q2 2021 Aug 10, 2021	SELL	$100.34 - $115.69 $2.35 Million - $2.71 Million	-23,465 Reduced 30.9%	52,473 $5.67 Million
Q1 2021 May 13, 2021	BUY	$101.51 - $125.27 $5.49 Million - $6.77 Million	54,055 Added 247.02%	75,938 $8 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $318,852 - $524,825	-6,640 Reduced 23.28%	21,883 $1.6 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $1.05 Million - $1.8 Million	28,523 New	28,523 $1.48 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account